Management of Conjunctival Melanoma: Critical Assessment of Sentinel Lymph Node Biopsy
Overview
Authors
Affiliations
Conjunctival melanoma (CoM) is a rare and aggressive form of melanoma. There is a lack of consensus on a unified management plan for this disease. Recently, a few centers have adopted the regional sentinel lymph node biopsy into the staging process of CoM. This study presents a critical assessment of the role of sentinel lymph node biopsy in CoM and presents a simplified management algorithm based on high-risk clinical and pathological features.
Melanoma and Nanotechnology-Based Treatment.
Zeng H, Li J, Hou K, Wu Y, Chen H, Ning Z Front Oncol. 2022; 12:858185.
PMID: 35356202 PMC: 8959641. DOI: 10.3389/fonc.2022.858185.
Current Management of Conjunctival Melanoma Part 1: Clinical Features, Diagnosis and Histopathology.
Koc I, Kiratli H Turk J Ophthalmol. 2020; 50(5):293-303.
PMID: 33342197 PMC: 7610047. DOI: 10.4274/tjo.galenos.2020.38096.
Echegaray J, Yeaney G, Chen R, Singh A Ocul Oncol Pathol. 2020; 6(4):287-292.
PMID: 33005619 PMC: 7506277. DOI: 10.1159/000505270.
Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights.
Mor J, Rokohl A, Koch K, Heindl L Clin Ophthalmol. 2019; 13:1297-1302.
PMID: 31440020 PMC: 6667347. DOI: 10.2147/OPTH.S187364.